BSE filing, NSE: JAINCO. Summary written from the filing by ALFA Finder's alert engine.
Jainco Projects (India) Ltd: key numbers
- Share price
- ₹4.20
- Market cap
- ₹4.20 Cr
- Revenue (annual)
- ₹0.75 Cr
- Net profit (annual)
- ₹0.01 Cr
- P/E (TTM)
- 646.1×Sector 19.7×
- Promoter holding
- 28.93%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jainco Projects (India) Ltd
All →Jainco Projects (India) Annual General Meeting
Jainco Projects (India) Limited conducted its 35th Annual General Meeting on September 30, 2026. Shareholders transacted the adoption of financial statements and the re-appointment of Director Sumit Bhansali.
Jainco Projects (India) Insolvency Petition
Jainco Projects (India) Ltd announced that the CIRP application filed against the company under section 7 of the IBC before the NCLT, Kolkata has been withdrawn.
Jainco Projects (India) Annual Report
Jainco Projects (India) Ltd has submitted its 35th Annual Report along with the AGM notice for the financial year 2025-26.
Jainco Projects (India) Annual General Meeting
Jainco Projects approved the Annual Report and scheduled its 35th Annual General Meeting for September 30, 2026. The Board also proposed re-appointing the Managing Director.
Jainco Projects (India) Board Meeting Date
Jainco Projects (India) Ltd has rescheduled its board meeting from September 1, 2026, to September 4, 2026. The meeting will deliberate on AGM-related business and appointments.
Jainco Projects (India) Other Announcement
Jainco Projects (India) Ltd has informed that the statement of deviation or variation under Regulation 32 is not applicable as it has no unutilized funds.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.